Kanion Pharmaceutical

Kanion Group is a large health industry group with main businesses in the production and distribution of innovative traditional Chinese medicine, biopharmaceuticals, and health products. Its industrial layout mainly involves five major sectors: pharmaceutical manufacturing, pharmaceutical commerce, ecological agriculture, international trade, and health services. Among these, the group's pharmaceutical manufacturing sector focuses on five key areas of advantage: traditional Chinese gynecological medicines, traditional Chinese orthopedic medicines, traditional Chinese cardiovascular and cerebrovascular medicines, traditional Chinese antiviral medicines, and botanical anti-tumor medicines. The group actively engages in innovative new drug research and development in these fields, achieving fruitful results. The group’s pharmaceutical commerce sector serves as a regionally powerful pharmaceutical reserve base and a main distribution channel, acting as the leading distributor of essential medicines in the region. It is also among China’s top 100 pharmaceutical distribution companies, top 100 retail enterprises, and a flagship enterprise in regional pharmaceutical retail.